NORDEA INVESTMENT MANAGEMENT AB

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 1218210 STOCKHOLM, V7

Position in AUPH

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$5,026,514

+$696,110 QoQ

Shares Held

296,200

+1.4% QoQ

Ownership

0.223%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#42

of 279 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

NORDEA INVESTMENT MANAGEMENT AB holds $503,679,873 across 20 Biotechnology names. AUPH ranks #13 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	363,479	$226,643,694
2	RPRX	Royalty Pharma plc	2,576,772	$144,479,604
3	ARWR	Arrowhead Pharmaceuticals, Inc.	284,175	$23,163,103
4	LGND	Ligand Pharmaceuticals Inc	49,943	$15,786,482
5	VRTX	Vertex Pharmaceuticals Inc / Ma	30,496	$15,148,278
6	EXEL	Exelixis, Inc.	210,314	$11,443,184
7	ALNY	Alnylam Pharmaceuticals, Inc.	26,913	$8,101,620
8	PTGX	Protagonist Therapeutics, Inc	64,964	$7,963,286

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$5,026,514	296,200	+1.4%	Shares	Defined	2026-08-05
2026-03-31	$4,330,404	292,200	-3.9%	Shares	Defined	2026-05-13
2025-12-31	$4,851,990	304,200	-15.3%	Shares	Defined	2026-01-08
2025-09-30	$3,968,055	359,100	+1.2%	Shares	Defined	2025-10-27
2025-06-30	$3,006,850	355,000	+1.5%	Shares	Defined	2025-07-29
2025-03-31	$2,810,784	349,600	+3.2%	Shares	Defined	2025-05-14
2024-12-31	$3,040,628	338,600	+0.3%	Shares	Sole	2025-01-06
2024-09-30	$2,474,608	337,600	-3.5%	Shares	Sole	2024-11-05
2024-06-30	$1,997,929	349,900	+13.4%	Shares	Sole	2024-08-08
2024-03-31	$1,545,585	308,500	+51.7%	Shares	Sole	2024-05-02
2023-12-31	$1,828,566	203,400	-5.2%	Shares	Sole	2024-01-10
2023-09-30	$1,666,665	214,500	+1.0%	Shares	Sole	2023-11-13
2023-06-30	$2,056,032	212,400	—	Shares	Sole	2023-07-07
No filing history on record for this holder in this stock.